Abstract:Our previous study revealed that Type II cGMP-dependent protein kinase (PKG II) inhibits epidermal growth factor (EGF)-induced MAPK/ERK and MAPK/JNK-mediated signal transduction through the inhibition of the phosphorylation/activation of the EGF receptor (EGFR). As EGFR also mediates several other signal transduction pathways besides MAPK-mediated pathways, the present study was designed to investigate whether PKG II was able to inhibit EGF/EGFR-induced phosphatidylinositol-3-kinase (PI3K)/Akt-mediated signal transduction. The AGS human gastric cancer cell line was infected with adenoviral constructs encoding a cDNA of PKG II (Ad-PKG II) to increase the expression of PKG II, and treated with 8-pCPT-cGMP to activate the enzyme. Western blotting was used to detect the phosphorylation/activation of the key components of the signal transduction pathway, including EGFR, PI3K, Akt, mTOR and NF-B. The levels of apoptosis-related proteins, including Bax, Bcl-2, caspase 9 and DNA fragment factor (DFF), were also determined by western blotting. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining was used to detect the apoptosis of the AGS cells. The results revealed that EGF treatment increased the phosphorylation (activation) of EGFR, PI3K, Akt and mTOR, and increased the nuclear localization (activation) of NF-B. EGF treatment also reduced the apoptosis of the AGS cells and increased the expression of the anti-apoptotic protein, Bcl-2, but had no effect on the expression of the pro-apoptotic protein, Bax, and did not alter the levels of caspase 9 and DFF. Increasing the PKG II activity of AGS cells by infecting them with Ad-PKG II and stimulating them with 8-pCPT-cGMP inhibited the EGF-induced activation of EGFR, PI3K, Akt, mTOR and NF-B; caused an increase in caspase 9 breakdown (activation) and DFF levels; and reversed the anti-apoptotic effect of EGF. The results suggest that PKG II may also inhibit EGF-induced signal transduction of PI3K/Akt-mediated pathways, and further confirm that PKG II is able to block the activation of EGFR.

Casein Kinase 2 Inhibitor CX-4945 Elicits an Anti-Warburg Effects Through the Downregulation of TAp73 and Inhibits Gastric Tumorigenesis

IC261, a Specific Inhibitor of CK1δ/ε, Promotes Aerobic Glycolysis Through P53-Dependent Mechanisms in Colon Cancer

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Akt associates with nuclear factor kappaB and plays an important role in chemoresistance of gastric cancer cells.

CK2 Phosphorylates and Inhibits TAp73 Tumor Suppressor Function to Promote Expression of Cancer Stem Cell Genes and Phenotype in Head and Neck Cancer.

Tipe2 Functions As A Metastasis Suppressor Via Negatively Regulating Beta-Catenin Through Activating Gsk3 Beta In Gastric Cancer

Crosstalk of mTOR/PKM2 and STAT3/c-Myc signaling pathways regulate the energy metabolism and acidic microenvironment of gastric cancer.

CMPD1 Inhibited Human Gastric Cancer Cell Proliferation by Inducing Apoptosis and G2/M Cell Cycle Arrest

SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases

P38mapk Signaling Enhances Glycolysis Through the Up-Regulation of the Glucose Transporter GLUT-4 in Gastric Cancer Cells

The constitutively active PKG II mutant effectively inhibits gastric cancer development a blockade of EGF/EGFR-associated signalling cascades.

3-Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth

Type Ii Cgmp-Dependent Protein Kinase Inhibits Activation Of Key Members Of The Rtk Family In Gastric Cancer Cells

Class I Phosphatidylinositol 3-Kinase Inhibitor LY294002 Activates Autophagy and Induces Apoptosis Through P53 Pathway in Gastric Cancer Cell Line SGC7901

Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.

Estradiol Cypionate Inhibits Proliferation and Promotes Apoptosis of Gastric Cancer by Regulating AKT Ubiquitination.

Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo

Targeting Inhibition of Extracellular Signal-Regulated Kinase Kinase Pathway with AZD6244 (ARRY-142886) Suppresses Growth and Angiogenesis of Gastric Cancer.

Tyrosine phosphatase SHP2 aggravates tumor progression and glycolysis by dephosphorylating PKM2 in gastric cancer

Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation.

Targeting Protein Kinase CK2 Suppresses Bladder Cancer Cell Survival Via the Glucose Metabolic Pathway.